2000 Honda Civic Si Ebp True Em1 R 1.6l Mint on 2040-cars

Auto blog

Honda names first woman, foreigner to its board of directors

General Motors may have made headlines when it recently appointed the industry's first female CEO, but Honda has long lagged woefully behind the times when it comes to the diversity of its top management. In fact, its entire board has until now been composed entirely of Japanese men, with not a foreigner or a woman in sight. But as Reuters reports, that's all changing with the nominations to its latest board.
The slate of new directors named to Honda's board includes one Hideko Kunii, a gender-equality advocate and engineering professor from the Shibaura Institute of Technology. A graduate of the University of Texas at Austin, Kunii spent the bulk of her career at Japanese electronic imaging company Ricoh. Alongside Kunii, Honda has also named Tomoko Mizoguchi to the board as responsible for the company's South American operations, making him the first foreigner to serve on the company's board of directors. (Well, almost: Mizoguchi was born in Brazil, but of Japanese ancestry.)
The appointments follow the recent switch Honda made in its official language policy from Japanese to English, signaling a shift in outlook for a company that has long stuck to traditional Japanese business models. Honda was the first of the major Japanese automakers to begin manufacturing in the United States, and has long relied on hiring local managers to run its regional operations around the world. It has, however, resisted placing foreigners on its board of directors until now, relying instead on senior male managers promoted from within its ranks to serve on its board. This in comparison to Toyota, which has seven foreigners and one woman on its 68-member board of directors, and Nissan, which has fifteen foreigners (including its chief executive) and one woman on its 58-member board.

Honda to dub Fit-based as HR-V for North America

You may remember it as the Urban SUV (pictured above) from when it debuted in concept form at the Detroit Auto Show last year, or know it as the Vezel as the production version was unveiled for the Japanese Domestic Market at the 2014 Tokyo Motor Show. But when Honda starts exporting its new Fit-based crossover - or better yet, building it in Mexico for North American consumption - it will be called the HR-V.
This news comes courtesy of Honda enthusiast forum Temple of VTEC. When contacted by Autoblog, Honda spokesmen declined to comment on the veracity of the report, saying only that it would "announce the name in the near future," but the handle fits with what we know about Honda's history with compact crossovers. The previous HR-V (which was not available in the States) was a high-riding, squared-off crossover built between 1999 and 2006 and based on the Fit's predecessor, the Honda Logo.
While the HR-V moniker might not have name recognition in North America, it would in Europe where Honda also hopes its new crossover will find eager customers. It will also fit in nicely below the CR-V that will continue on as the HR-V's larger stablemate.

Honda Walking Assist Device begins US testing at Rehabilitation Institute of Chicago

For years, we've been wondering what implications Honda's Asimo robot could have in the real world, and now we're starting to get a sense of that. Honda announced that it will begin its first US clinical studies of the Walking Assist Device at the Rehabilitation Institute of Chicago in an effort to provided improved mobility for people who have suffered a stroke. While the automotive tie-in here is pretty weak, this is the first time we've heard about this device since it was unveiled back in 2008.
Weighing in at six pounds, Honda's device is fitted to the waist and legs of patients to make it easier to walk, and the 22.2-volt lithium-ion battery provides enough electricity for more than an hour of operation. According to Honda's press release, which is posted below, up to 80 percent of the almost 800,000 stroke victims each year (in the US alone) are afflicted with limited mobility, so a medical aid like this could have a big impact in the real world.